Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

AI drug development startup Pathos AI closes $237M investment

Дата публикации: 23-10-2026 20:02:03

Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers. Pathos’ investor roster includes big names such as AstraZeneca plc, NEA and General Atlantic. Pathos is developing cancer drugs […]
The post AI drug development startup Pathos AI closes $237M investment appeared first on SiliconANGLE.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry07.2322-10-2026
2AI Drug Discovery Biz Valued At $3.8B After Series C Round0514-07-2026
3AI cloud start-up Volta valued at $2.4bn, inks $10bn Anthropic deal09.3805-08-2026
4Anthropic Quietly Launches Biolab for Drug Development - Reports010.8518-09-2026
5UK AI Chip Start-Up Fractile Raises $220m014.4914-05-2026
6Accel raises $3.5 billion to invest in emerging global AI startups 010.3912-08-2026
7Supabase raises $500M as AI coding tools drive ‘phenomenal’ growth011.105-06-2026
8Prevalent AI raises first outside capital in nine years with $22M round06.5719-08-2026
9Anthropic Raising $20bn At $350bn Valuation012.2228-01-2026
10Market data platform startup Databento closes $97M round after drawing $300M in investor demand07.5309-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.13. Источник: siliconangle.com.